Lobo, L. et al. 2024. Tenapanor-A Novel Approach for Management of Hyperphosphatemia in End Stage Renal Disease: A Clinical Study Aggregate Review: CLINICAL STUDY AGGREGATE REPORT. Journal of Drug Delivery and Therapeutics. 14, 1 (Jan. 2024), 176–181. DOI:https://doi.org/10.22270/jddt.v14i1.6336.